Insider Bets Paying Off At SRPT As New 52-Week High Reached

In trading on Wednesday, shares of Sarepta Therapeutics Inc ( SRPT) touched a new 52-week high of $33.16/share. That's a 192.67% rise, or $21.83 per share from the 52-week low of $11.33 set back on 01/14/2015. That means at today's intraday high, any investor who purchased SRPT stock any time over the past 52 weeks has an unrealized gain, including company insiders.

Over the past six months, insiders have been scooping up shares, and those bets are now paying off handsomely. As summarized by the table below, SRPT has seen 2 different instances of insiders buying over the trailing six month period.

START SLIDESHOW:
Ten Bargains You Can Buy Cheaper Than The Insiders Did »

Purchased Insider Title Shares Price/Share Value
02/27/2015 Edward M. Kaye, M.D. SVP & Chief Medical Officer 800 $11.81 $9,452.00
02/27/2015 Nishan Garabedian Christopher President and CEO 800 $11.81 $9,452.00

The chart below shows where SRPT has traded over the past year, with the 50-day and 200-day moving averages included.

Sarepta Therapeutics Inc Moving Averages Chart

In afternoon trading on Wednesday, SRPT shares are changing hands at $32.64/share, slightly below the new 52-week high.

If you liked this article you might like

With an Eye on Biotech, Here's Today's Trading Thesis

With an Eye on Biotech, Here's Today's Trading Thesis

Focused on Two Sectors

Focused on Two Sectors

Solid Biosciences Soars 41% in IPO Despite Late Disclosure of FDA Letter

Solid Biosciences Soars 41% in IPO Despite Late Disclosure of FDA Letter

In This Booming Stock Market, Think Like a Programmer Not a Critic

In This Booming Stock Market, Think Like a Programmer Not a Critic

How Trading Notes Can Increase Your Profits

How Trading Notes Can Increase Your Profits